Buprenorphine Prescribing Document - References

  1. Pergolizzi JV, LeQuang JA, Berger GK, Raffa RB. The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review. Pain Ther. 2017;6(1):1-16. doi:10.1007/s40122-017-0068-3. https://pubmed.ncbi.nlm.nih.gov/28341939
  2. Fitzgerald Jones K, Khodyakov D, Arnold R, et al. Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder. JAMA Oncol. 2022;8(8):1107. doi:10.1001/jamaoncol.2022.2191. https://pubmed.ncbi.nlm.nih.gov/35771550/
  3. Webster L, Gudin J, Raffa RB, et al. Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion. Pain Med. 2020;21(4):714-723. doi:10.1093/pm/pnz356. https://pubmed.ncbi.nlm.nih.gov/31917418/
  4. U.S. Department of Veterans Affairs. Buprenorphine for the management of chronic pain: National guidance document: March 2024. Accessed August 29, 2024. https://www.va.gov/formularyadvisor/DOC_PDF/CRE_Buprenorphine_for_Chronic_Pain_MAR_2024.pdf
  5. Hickey T, Abelleira A, Acampora G, et al. Perioperative Buprenorphine Management. Med Clin North Am. 2022;106(1):169-185. doi:10.1016/j.mcna.2021.09.001. https://pubmed.ncbi.nlm.nih.gov/34823729/
  6. D’Onofrio G, Hawk K, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108-e236108. doi:10.1001/jamanetworkopen.2023.6108. https://pubmed.ncbi.nlm.nih.gov/36995717/
  7. Aiyer R, Gulati A, Gungor S, Bhatia A, Mehta N. Treatment of Chronic Pain With Various Buprenorphine Formulations. Anesth Analg. 2018;127(2):529-538. doi:10.1213/ane.0000000000002718. https://pubmed.ncbi.nlm.nih.gov/29239947/
  8. Childers J, Arnold R, et al. Fast Fact #268: Low-Dose Buprenorphine Patch for Pain. Palliative Care Network of Wisconsin. 2019. Accessed August 29, 2024. https://www.mypcnow.org/fast-fact/low-dose-buprenorphine-patch-for-pain/
  9. J. Janet Ho, Katie Fitzgerald Jones, Merlin JS, Sager Z, Childers J. Buprenorphine Initiation: Low-Dose Methods #457. JAMA Netw Open. 2023;26(6):867-869. doi:10.1089/jpm.2023.0047. https://pubmed.ncbi.nlm.nih.gov/37276524/
  10. Becker WC, Frank JW, Edens EL. Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series. Ann Intern Med. 2020;173(1):70-71. doi:10.7326/l19-0725. https://pubmed.ncbi.nlm.nih.gov/32252072/
  11. U.S. Department of Veterans Affairs, U.S. Department of Defense. VA/DoD Clinical Practice Guideline: Use of opioids in the management of chronic pain work group. 2022. Washington, DC: U.S. Government Printing Office.
  12. Meyer-Junco L, Rea B, Mendoza K, Fudin J. Application Site Reactions from the Buprenorphine Transdermal Patch: A Case Series. J Pain Palliat Care Pharmacother. 2022;36(1):49-54. doi:10.1080/15360288.2022.2051676. https://pubmed.ncbi.nlm.nih.gov/35332848/‌
  13. Reindel KL, DeAngelis MJ, Ferrara AS, et al. An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability. Int J Pharm Compd. 2019;23(3):258-263. https://pubmed.ncbi.nlm.nih.gov/31085795/

Get the latest updates in your inbox!